Alliancebernstein L.P. Tg Therapeutics, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 174,020 shares of TGTX stock, worth $7.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
174,020
Previous 193,570
10.1%
Holding current value
$7.11 Million
Previous $4.53 Million
15.71%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$637 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$465 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$376 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$130 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$114 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.93B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...